logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Zoltan G Hajos

USPTO Granted Patents = 19

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Bloomsbury, NJ (US) (1981)
  • Budapest, HU (1992)
  • Princeton, NJ (US) (1980 - 1993)

Company Filing History:

goldMedal19 out of 377 
 
Ortho Pharmaceutical Corporation
 patents

Years Active: 1980-1993

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5252569 - 6-substituted purinyl piperazine derivatives (1993-10-12),
2. 5215987 - Substituted benzhydryl 2-hydroxypropyl piperazine derivatives (1993-06-01),
3. 5164390 - 6-substituted purinyl piperazine derivatives (1992-11-17),
4. 5106863 - Substituted imidazole and pyridine derivatives (1992-04-21),
5. 5021574 - 6-substituted purinyl piperazine derivatives (1991-06-04),
6. 5001127 - 4-substituted pyrazolo[3,4-d]pyrimidine derivatives (1991-03-19),
7. 4885300 - 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives (1989-12-05),
8. 4876257 - 6-Substituted purinyl piperazine derivatives useful as cardiotonic and (1989-10-24),
9. 4603213 - Total synthesis of (1986-07-29),
10. 4482730 - Synthesis of dioxabicyclo[3.2.1]octanes and oxepanes (1984-11-13),
11. 4387234 - Synthesis of dioxabicyclo[3.2.1]octanes and oxepanes (1983-06-07),
12. 4329288 - ( (1982-05-11),
13. 4322353 - Synthesis of dioxabicyclo(3.2.1)octanes and oxepanes (1982-03-30),
14. 4307019 - Total synthesis of (1981-12-22),
15. 4284565 - Total synthesis of (1981-08-18),

Title: Celebrating the Innovations of Zoltan G. Hajos

Introduction: Zoltan G. Hajos, based in Princeton, NJ, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 19 patents, he is recognized for his groundbreaking work in developing novel compounds that serve critical medical purposes.

Latest Patents: Among his latest innovations are the 6-substituted purinyl piperazine derivatives, which are described as novel compounds useful as cardiotonic agents and antiarrhythmic agents. Additionally, he has developed substituted benzhydryl 2-hydroxypropyl piperazine derivatives, which also hold promise as cardiotonic agents and include methods of synthesis for these derivatives.

Career Highlights: Zoltan has established himself as a prominent inventor and researcher at Ortho Pharmaceutical Corporation. His dedication to advancing pharmaceutical science is evident in his extensive work and the impact of his patents on the industry.

Collaborations: Throughout his career, Zoltan has collaborated with esteemed colleagues including Jeffery B. Press and Michael P. Wachter. These partnerships have enhanced the breadth of his research and contributed to the success of his innovations.

Conclusion: Zoltan G. Hajos exemplifies the spirit of innovation in modern medicine. His ongoing contributions through his patents continue to influence the development of valuable therapeutic agents, showcasing the vital role inventors play in enhancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…